SCHEMBL3093207

SCHEMBL3093207

C1CCOCC1.C1CCOCC1.CC(Cl)Cl

nearest known ligand 0.53

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.53
TSHR P16473 2/20 0.40
TTR P02766 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrahydrofuran SCHEMBL2975678 0.97
Tetrahydrofuran SCHEMBL28820736 0.93
Tetrahydrofuran SCHEMBL3618483 0.90 ALDH1A1 (0.57) ALDH1A1TSHRTTR
Tetrahydrofuran SCHEMBL28088571 0.85 ALDH1A1 (0.44) ALDH1A1TSHR
Tetrahydrofuran SCHEMBL11521890 0.82
Tetrahydrofuran SCHEMBL193538 0.82
Dioxane SCHEMBL3093215 0.82 ALDH1A1 (0.50) ALDH1A1TSHRTTR
Chloromethane SCHEMBL27584162 0.82
Tetrahydrofuran SCHEMBL2812148 0.80 ALDH1A1 (0.53) ALDH1A1TSHRTTR
Isopropyl Alcohol SCHEMBL9004332 0.80 ALDH1A1 (0.53) ALDH1A1TSHRTTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399455-B2 Compounds useful as chemokine receptor antagonists MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-03-19 US disclosed
US-20100234356-A1 COMPOUNDS USEFUL AS CHEMOKINE RECEPTOR ANTAGONISTS MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-09-16 US disclosed
US-4033981-A ANTIHISTOMINIC, ANTIINFLAMMATORY, SEDATIVES, DIURETICS WARNER-LAMBERT COMPANY (US) 1977-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234356-A1 COMPOUNDS USEFUL AS CHEMOKINE RECEPTOR ANTAGONISTS ACKR3, CCR5, CXCR2 ALDH1A1 1889/4885TSHR 696/4885TTR 4778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.